Since about two-thirds of patients with this phenotype have IgM paraproteinemic neuropathy and often anti-MAG antibodies [52], EAN/PNS guidelines recommend testing an IgM protein and an anti-MAG antibody in patients with distal CIDP phenotype and repeating them if they are negative [1]. This evidence concerns the gene MAG and paraneoplastic neurologic syndrome.